VyrarX review

VyrarX is a service-model option for eligible adults willing to obtain a complete quote before enrolling. Its public starting prices and partner links are useful leads, but do not establish an all-inclusive medication bundle or verify the care assignment for a particular patient.

VyrarX is the public brand of vyrarx Inc., the business named in its legal disclosures. It describes a telehealth pathway connecting patients with healthcare professionals for prescription weight care, alongside broader anti-aging and recovery programs. Prescription decisions remain with the clinician and are not guaranteed.

The public homepage FAQ identifies Rush Pharmacy as a pharmacy and Locum Tele as the provider network, linking to each. Those are the platform’s relationship disclosures. They do not independently verify licensing, establish a particular medical-practice roster or confirm which clinician and pharmacy would handle your prescription.

The weight program specifically names semaglutide and tirzepatide. Broader NAD+ and longevity-peptide categories do not establish molecule-specific prices, formulations or routes, so they add little to a concrete medication comparison. Ask for the actual proposed treatment instead of treating a category heading as a complete product offer.

The advertised process is a short health questionnaire, physician review, a treatment decision and medication delivery if prescribed. The homepage estimates questionnaire completion around five minutes and review within twenty-four hours. It describes care-team messaging, regular follow-up, nutrition or lifestyle coaching and clinician-directed changes. These are provider process claims; actual response speed, visit access and delivery timing are not established.

Terms require age eighteen or older and residence in an eligible U.S. state. The site claims forty-seven-state care and explicitly excludes California, South Carolina and New Jersey. A clinical BMI rule and treatment-specific laboratory requirements are not established. Confirm availability where you will receive care and whether the proposed prescription requires additional visits or testing.

Free shipping is advertised, but preparation time, shipment cadence and supplied quantity are not specified. The recovery category mentions laboratory work and follow-ups; that does not establish laboratory inclusion for the GLP-1 weight program. An itemized plan should distinguish what belongs to your treatment from services advertised for another category.

The homepage advertises semaglutide starting at $179 per month and tirzepatide starting at $329 per month. These are seller starting-price claims. They do not establish the full initial charge, ordinary renewal amount, dose tier, prepaid commitment, day supply or whether medication, consultation and platform costs are all included. No introductory-versus-renewal difference can be assumed.

VyrarX says insurance is not needed and shipping is free. The terms require payment when services are provided and say fees are shown before the transaction. Insurance billing, HSA/FSA handling and reimbursement assistance are not established. Before paying, request the complete first charge, later charges, billing interval, medication quantity and every separate clinical or laboratory fee.

The refund policy permits subscription cancellation at any time, taking effect at the end of the current billing cycle. It generally provides no partial-period refund unless required by law. The exact renewal interval, advance notice deadline and cancellation control are not supplied, so obtain written instructions and confirmation for the plan you select.

For medication orders, the general no-refund wording applies after the prescription has been sent to the pharmacy and the medication has shipped. It describes possible exceptions for damage or defects, the wrong medication or dose, and cancellation before shipment. That wording does not establish that pharmacy transmission alone ends every refund possibility, nor does it promise a refund for every unshipped order.

Refund requests must reach the published support channel within thirty days of purchase. The policy aims to review requests within five to seven business days and return approved refunds to the original payment method within five to ten business days. A clinical-denial refund guarantee is not established. Keep the selected plan’s terms and charge confirmation rather than assuming cancellation refunds the current cycle.

The semaglutide program card describes weekly injections. The tirzepatide card names the molecule and GLP-1/GIP pathway without settling its route. Neither offer establishes the exact branded-versus-compounded preparation, additives, concentration or supplied quantity.

The FAQ’s general discussion of pharmacy regulation does not classify the named pharmacy or prove FDA approval of the proposed medicine. Confirm the prescription’s approval status, preparation, route, storage and follow-up with the actual clinician and pharmacy. The public evidence is insufficient to label the weight-care offer definitively branded-only or compounded, and price alone cannot resolve that question.